Vaxart expands IP portfolio with European patent protection
Vaxart expanded its intellectual property portfolio with a European patent protecting proprietary norovirus vaccine technology.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.